Clark David J 4
4 · Aldeyra Therapeutics, Inc. · Filed Sep 10, 2019
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Purchase
Common Stock
2019-09-06$5.06/sh+5,000$25,311→ 17,878 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]Includes 1,366 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019.